Northern Trust’s Opus Genetics IRD Stock Holding History

Northern Trust’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$430K	Buy	94,415 +6,968	+8%	+$24.1K	﹤0.01%	3671
2025 Q4	$176K	Buy	87,447 +19,219	+28%	+$39K	﹤0.01%	4021
2025 Q3	$113K	Hold	68,228	–	–	﹤0.01%	4109
2025 Q2	$64.3K	Hold	68,228	–	–	﹤0.01%	4195
2025 Q1	$67K	Buy	68,228 +40,961	+150%	+$45.8K	﹤0.01%	4190
2024 Q4	$32.4K	Hold	27,267	–	–	﹤0.01%	4326
2024 Q3	$35.7K	Hold	27,267	–	–	﹤0.01%	4261
2024 Q2	$41.7K	Sell	27,267 -24,658	-47%	-$42.6K	﹤0.01%	4234
2024 Q1	$104K	Hold	51,925	–	–	﹤0.01%	4069
2023 Q4	$156K	Buy	51,925 +21,055	+68%	+$62.3K	﹤0.01%	3983
2023 Q3	$103K	Sell	30,870 -297	-1%	-$1.19K	﹤0.01%	4008
2023 Q2	$135K	Sell	31,167 -903	-3%	-$4.29K	﹤0.01%	3957
2023 Q1	$120K	Buy	32,070 +9,789	+44%	+$35.1K	﹤0.01%	4036
2022 Q4	$78.7K	Hold	22,281	–	–	﹤0.01%	4172
2022 Q3	$45K	Hold	22,281	–	–	﹤0.01%	4351
2022 Q2	$43K	Buy	22,281 +1,535	+7%	+$3.49K	﹤0.01%	4450
2022 Q1	$67K	Buy	20,746 +150	+0.7%	+$513	﹤0.01%	4460
2021 Q4	$77K	Buy	20,596 +8,465	+70%	+$33.9K	﹤0.01%	4499
2021 Q3	$62K	Buy	+12,131	New	+$55.9K	﹤0.01%	4495
2019 Q2	–	Sell	-2,077	Closed	-$51K	–	4301
2019 Q1	$51K	Buy	2,077 +356	+21%	+$11.8K	﹤0.01%	4035
2018 Q4	$77K	Hold	1,721	–	–	﹤0.01%	3974
2018 Q3	$147K	Hold	1,721	–	–	﹤0.01%	3939
2018 Q2	$116K	Buy	1,721 +112	+7%	+$9.84K	﹤0.01%	3987
2018 Q1	$117K	Buy	1,609 +612	+61%	+$55.6K	﹤0.01%	3943
2017 Q4	$97K	Hold	997	–	–	﹤0.01%	3978
2017 Q3	$116K	Hold	997	–	–	﹤0.01%	3923
2017 Q2	$137K	Buy	997 +363	+57%	+$70.6K	﹤0.01%	3903
2017 Q1	$155K	Buy	634 +177	+39%	+$22.9K	﹤0.01%	3861
2016 Q4	$31K	Buy	457 +13	+3%	+$1.06K	﹤0.01%	4059
2016 Q3	$45K	Hold	444	–	–	﹤0.01%	4017
2016 Q2	$53K	Hold	444	–	–	﹤0.01%	4002
2016 Q1	$70K	Hold	444	–	–	﹤0.01%	3971
2015 Q4	$77K	Hold	444	–	–	﹤0.01%	3988
2015 Q3	$111K	Buy	444 +35	+9%	+$9.51K	﹤0.01%	3909
2015 Q2	$119K	Sell	409 -80	-16%	-$27.2K	﹤0.01%	3918
2015 Q1	$171K	Hold	489	–	–	﹤0.01%	3909
2014 Q4	$164K	Hold	489	–	–	﹤0.01%	3865
2014 Q3	$190K	Sell	489 -1	-0.2%	-$360	﹤0.01%	3848
2014 Q2	$205K	Buy	490 +75	+18%	+$34.1K	﹤0.01%	3856
2014 Q1	$215K	Buy	415 +222	+115%	+$120K	﹤0.01%	3765
2013 Q4	$47K	Hold	193	–	–	﹤0.01%	3981
2013 Q3	$42K	Sell	193 -10	-5%	-$2.33K	﹤0.01%	3953
2013 Q2	$43K	Buy	+203	New	+$34.8K	﹤0.01%	3947

Other funds holding IRD

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Northern Trust's IRD Position: Q1 2026 in Review

Northern Trust increased its Opus Genetics (IRD) stake by 8% in Q1 2026, buying an estimated $24.1K and bringing the position to 94,415 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #3671.

Northern Trust first reported a position in IRD in Q2 2013 and has held it in 43 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

Northern Trust held 94,415 shares of Opus Genetics worth $430K as of Q1 2026.
Northern Trust bought 6,968 Opus Genetics shares in Q1 2026, an estimated $24.1K.
Opus Genetics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3671 holding.
Northern Trust first reported a position in Opus Genetics in Q2 2013 and has held it in 43 quarters since.
79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.